Skip to main content

Table 2 Cost-effectiveness of PMTCT of HIV in Liangshan Prefecture, Sichuan province in China

From: Cost-effectiveness analysis of the prevention of mother-to-child transmission of HIV

Items

Value

Costs (USD in million)

 

 PMTCT (HIV test, ART, etc.)

114.1

Effectiveness

 

 No. of pregnant women preliminary tested for HIV

34,991

 No. of identified HIV + women

663

 No. of HIV + women volunteering to terminate pregnancy

28

 No. pediatric infections averted

164

 Life years gained (person-years)

630.6

 Direct benefits (USD in million)

198.4

 Indirect benefits (USD in million)

82.5

Cost-effectiveness

 

 Cost per pregnant women preliminary screening tested for HIV (USD)

3.5

 Cost per pregnant women reinspected for HIV (USD)

296.6

 Cost per pediatric infections averted (USD)

6957.9

 Cost utility ratio

1809.5

 Benefit–cost ratio

1.5

  1. PMTCT prevention of mother-to-child transmission, HIV human immunodeficiency virus, ART antiretroviral therapy